Michael Kagan

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D₂Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

Richard E. Mewshaw, Joseph J. Kavanagh, Gary Stack et al. · Journal of Medicinal Chemistry · 1997 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and 5-Hydroxytryptamine (5-HT) activity of 2,3,4,4a-Tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-Hexahydro-1H-pyrazino[1,2-a]quinoxalines

Gregory S. Welmaker, James A. Nelson, Joan Sabalski et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Polysulfated Carbohydrates Analyzed as Ion-paired Complexes with Basic Peptides and Proteins Using Electrospray Negative Ionization Mass Spectrometry

Marshall M. Siegel, Keiko Tabei, Michael Kagan et al. · Journal of Mass Spectrometry · 1997 · 31 citations

Life Sciences, Biochemistry, Carbohydrate Biochemistry +14

Normal-phase high-performance liquid chromatographic separations using ethoxynonafluorobutane as hexane alternative

Michael Kagan · Journal of Chromatography A · 2001 · 29 citations

Pharmacy, Chemical Engineering, Analytical Chemistry +12

Advances toward New Antidepressants with Dual Serotonin Transporter and 5-HT_1AReceptor Affinity within a Class of 3-Aminochroman Derivatives. Part 2

Nicole T. Hatzenbuhler, Reinhardt B Baudy, Deborah A. Evrard et al. · Journal of Medicinal Chemistry · 2008 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17